Over a median follow-up period of @ months , a primary end-point event occurred in @ of @ patients in the CTA group ( @ % ) and in @ of @ ( @ % ) in the functional-testing group ( adjusted hazard ratio , @ ; @ % confidence interval , @ to @ ; P = @ ) .